Polymerase Chain Reaction (PCR) Market by Product (Instruments, Reagents and Consumables and Software) and End User: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023
The report covers forecast and analysis for the polymerase chain reaction market on a global and regional level. The study provides historic data of 2015 to 2017 along with a forecast from 2018 to 2023 based on revenue (USD Billion). The study includes drivers and restraints for the polymerase chain reaction market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the polymerase chain reaction market on a global level.
In order to give the users of this report a comprehensive view on the polymerase chain reaction market, we have included a competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new product launch, agreements, partnerships, collaborations joint ventures, research development, product and regional expansion of major participants involved in the market.
The study provides a decisive view on the polymerase chain reaction market by segmenting the market based on products, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Based on product, the market is segmented into instruments, reagents and consumables and software. Based on the end user, the market is segregated into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals and academic and research organization. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including the U.S., U.K., Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for polymerase chain reaction market based on technology in all the regions and countries.
The report also includes detailed profiles of end players such as Affymetrix, Inc., Agilent Technologies, Inc., Sigma Aldrich Corporation, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, QIAGEN, Becton Dickinson Company and Thermo Fischer Scientific.
This report segments the global polymerase chain reaction market as follows:
Global Polymerase Chain Reaction Market: Product Segment Analysis
In order to give the users of this report a comprehensive view on the polymerase chain reaction market, we have included a competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new product launch, agreements, partnerships, collaborations joint ventures, research development, product and regional expansion of major participants involved in the market.
The study provides a decisive view on the polymerase chain reaction market by segmenting the market based on products, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Based on product, the market is segmented into instruments, reagents and consumables and software. Based on the end user, the market is segregated into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals and academic and research organization. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including the U.S., U.K., Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for polymerase chain reaction market based on technology in all the regions and countries.
The report also includes detailed profiles of end players such as Affymetrix, Inc., Agilent Technologies, Inc., Sigma Aldrich Corporation, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, QIAGEN, Becton Dickinson Company and Thermo Fischer Scientific.
This report segments the global polymerase chain reaction market as follows:
Global Polymerase Chain Reaction Market: Product Segment Analysis
- Instruments
- Standard PCR Systems
- Real-Time PCR Systems
- Digital PCR Systems
- Reagents and Consumables
- Software
- Pharmaceutical and Biotechnology Industries
- Clinical Diagnostics Labs and Hospitals
- Academics and Research Organization
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
CHAPTER 1. INTRODUCTION
1.1. Report Description and Scope
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Global Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
2.2. Global Polymerase Chain Reaction Market: Snapshot
CHAPTER 3. POLYMERASE CHAIN REACTION MARKET MARKET DYNAMICS
3.1. Introduction
3.2. Market Drivers
3.2.1. Global Polymerase Chain Reaction Market Drivers: Impact Analysis
3.2.2. Increasing Number of Hospitals and Research Center
3.2.3. The rise in Government Funding
3.3. Market Restraints
3.3.1. Global Polymerase Chain Reaction Market Restraints: Impact Analysis
3.3.2. Reimbursement issues
3.4. Opportunities
3.4.1. Increase in Genetic Diseases
3.5. Porters Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. The threat of New Entrants
3.5.4. The threat of New Substitutes
3.5.5. Degree of Competition
3.6. Market Attractiveness Analysis
3.6.1. Market Attractiveness Analysis, by Product Segment
3.6.2. Market Attractiveness Analysis, by End-User Segment
3.6.3. Market Attractiveness Analysis, by Regional Segment
CHAPTER 4. GLOBAL POLYMERASE CHAIN REACTION MARKET COMPETITIVE LANDSCAPE
4.1. Company Market Share Analysis
4.1.1. Global Polymerase Chain Reaction Market: Company Market Share, 2017
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Therapy Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research And Development and Regional Expansion
4.3. Price Trend Analysis
CHAPTER 5. GLOBAL POLYMERASE CHAIN REACTION MARKET PRODUCT SEGMENT ANALYSIS
5.1. Global Polymerase Chain Reaction Market: Product Overview
5.1.1. Global Polymerase Chain Reaction Market Revenue Share, by Product, 2017 and 2023
5.2. Instruments
5.2.1. Global Polymerase Chain Reaction Market for Instruments, 2015 2023 (USD Billion)
5.3. Reagents and Consumables
5.3.1. Global Polymerase Chain Reaction Market for Reagents and Consumables, 2015 2023 (USD Billion)
5.4. Software
5.4.1. Global Polymerase Chain Reaction Market for Software, 2015 2023 (USD Billion)
CHAPTER 6. GLOBAL POLYMERASE CHAIN REACTION MARKET END-USER SEGMENT ANALYSIS
6.1. Global Polymerase Chain Reaction Market: End User Overview
6.1.1. Global Polymerase Chain Reaction Market Revenue Share, by End User, 2017 and 2023
6.2. Pharmaceutical and Biotechnology Industries
6.2.1. Global Polymerase Chain Reaction Market for Pharmaceutical and Biotechnology Industries, 2015 2023 (USD Billion)
6.3. Clinical Diagnostics Labs and Hospitals
6.3.1. Global Polymerase Chain Reaction Market for Clinical Diagnostics Labs and Hospitals, 2015 2023 (USD Billion)
6.4. Academic and Research Organizations
6.4.1. Global Polymerase Chain Reaction Market for Academic and Research Organizations, 2015 2023 (USD Billion)
CHAPTER 7. GLOBAL POLYMERASE CHAIN REACTION MARKET REGIONAL SEGMENT ANALYSIS
7.1. Global Polymerase Chain Reaction Market: Regional Overview
7.1.1. Global Polymerase Chain Reaction Market Revenue Share, by Region, 2017 And 2023
7.2. North America
7.2.1. North America Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.2.2. North America Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.2.3. North America Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.2.4. U.S.
7.2.4.1. U.S. Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.2.4.2. U.S. Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.3. Europe
7.3.1. Europe Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.3.2. Europe Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.3.3. Europe Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.3.4. UK
7.3.4.1. UK Polymerase Chain Reaction Revenue, by Product, 2015 2023 (USD Billion)
7.3.4.2. UK Polymerase Chain Reaction Revenue, by End User, 2015 2023 (USD Billion)
7.3.4.3.
7.3.5. Germany
7.3.5.1. Germany Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.3.5.2. Germany Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.3.6. France
7.3.6.1. France Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.3.6.2. France Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.4.2. Asia Pacific Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.4.3. Asia Pacific Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.4.4. China
7.4.4.1. China Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.4.4.2. China Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.4.5. Japan
7.4.5.1. Japan Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.4.5.2. Japan Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.4.6. India
7.4.6.1. India Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.4.6.2. India Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.5. Latin America
7.5.1. Latin America Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.5.2. Latin America Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.5.3. Latin America Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.5.4. Brazil
7.5.4.1. Brazil Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.5.4.2. Brazil Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.6.2. Middle East and Africa Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.6.3. Middle East and Africa Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
CHAPTER 8. COMPANY PROFILE
8.1. Affymetrix, Inc.
8.1.1. Overview
8.1.2. Financials
8.1.3. Therapy portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. Agilent Technologies, Inc.
8.2.1. Overview
8.2.2. Financials
8.2.3. Therapy portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. Sigma Aldrich Corporation
8.3.1. Overview
8.3.2. Financials
8.3.3. Therapy portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. Abbott Laboratories
8.4.1. Overview
8.4.2. Financials
8.4.3. Therapy portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. Beckman Coulter
8.5.1. Overview
8.5.2. Financials
8.5.3. Therapy portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. Bio-Rad Laboratories
8.6.1. Overview
8.6.2. Financials
8.6.3. Therapy portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. GE Healthcare
8.7.1. Overview
8.7.2. Financials
8.7.3. Therapy portfolio
8.7.4. Business strategy
8.7.5. Recent developments
8.8. QIAGEN
8.8.1. Overview
8.8.2. Financials
8.8.3. Therapy portfolio
8.8.4. Business strategy
8.8.5. Recent developments
8.9. Becton Dickinson Company
8.9.1. Overview
8.9.2. Financials
8.9.3. Therapy portfolio
8.9.4. Business strategy
8.9.5. Recent developments
8.10. Thermo Fischer
8.10.1. Overview
8.10.2. Financials
8.10.3. Therapy portfolio
8.10.4. Business strategy
8.10.5. Recent developments
1.1. Report Description and Scope
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Global Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
2.2. Global Polymerase Chain Reaction Market: Snapshot
CHAPTER 3. POLYMERASE CHAIN REACTION MARKET MARKET DYNAMICS
3.1. Introduction
3.2. Market Drivers
3.2.1. Global Polymerase Chain Reaction Market Drivers: Impact Analysis
3.2.2. Increasing Number of Hospitals and Research Center
3.2.3. The rise in Government Funding
3.3. Market Restraints
3.3.1. Global Polymerase Chain Reaction Market Restraints: Impact Analysis
3.3.2. Reimbursement issues
3.4. Opportunities
3.4.1. Increase in Genetic Diseases
3.5. Porters Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. The threat of New Entrants
3.5.4. The threat of New Substitutes
3.5.5. Degree of Competition
3.6. Market Attractiveness Analysis
3.6.1. Market Attractiveness Analysis, by Product Segment
3.6.2. Market Attractiveness Analysis, by End-User Segment
3.6.3. Market Attractiveness Analysis, by Regional Segment
CHAPTER 4. GLOBAL POLYMERASE CHAIN REACTION MARKET COMPETITIVE LANDSCAPE
4.1. Company Market Share Analysis
4.1.1. Global Polymerase Chain Reaction Market: Company Market Share, 2017
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Therapy Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research And Development and Regional Expansion
4.3. Price Trend Analysis
CHAPTER 5. GLOBAL POLYMERASE CHAIN REACTION MARKET PRODUCT SEGMENT ANALYSIS
5.1. Global Polymerase Chain Reaction Market: Product Overview
5.1.1. Global Polymerase Chain Reaction Market Revenue Share, by Product, 2017 and 2023
5.2. Instruments
5.2.1. Global Polymerase Chain Reaction Market for Instruments, 2015 2023 (USD Billion)
5.3. Reagents and Consumables
5.3.1. Global Polymerase Chain Reaction Market for Reagents and Consumables, 2015 2023 (USD Billion)
5.4. Software
5.4.1. Global Polymerase Chain Reaction Market for Software, 2015 2023 (USD Billion)
CHAPTER 6. GLOBAL POLYMERASE CHAIN REACTION MARKET END-USER SEGMENT ANALYSIS
6.1. Global Polymerase Chain Reaction Market: End User Overview
6.1.1. Global Polymerase Chain Reaction Market Revenue Share, by End User, 2017 and 2023
6.2. Pharmaceutical and Biotechnology Industries
6.2.1. Global Polymerase Chain Reaction Market for Pharmaceutical and Biotechnology Industries, 2015 2023 (USD Billion)
6.3. Clinical Diagnostics Labs and Hospitals
6.3.1. Global Polymerase Chain Reaction Market for Clinical Diagnostics Labs and Hospitals, 2015 2023 (USD Billion)
6.4. Academic and Research Organizations
6.4.1. Global Polymerase Chain Reaction Market for Academic and Research Organizations, 2015 2023 (USD Billion)
CHAPTER 7. GLOBAL POLYMERASE CHAIN REACTION MARKET REGIONAL SEGMENT ANALYSIS
7.1. Global Polymerase Chain Reaction Market: Regional Overview
7.1.1. Global Polymerase Chain Reaction Market Revenue Share, by Region, 2017 And 2023
7.2. North America
7.2.1. North America Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.2.2. North America Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.2.3. North America Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.2.4. U.S.
7.2.4.1. U.S. Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.2.4.2. U.S. Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.3. Europe
7.3.1. Europe Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.3.2. Europe Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.3.3. Europe Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.3.4. UK
7.3.4.1. UK Polymerase Chain Reaction Revenue, by Product, 2015 2023 (USD Billion)
7.3.4.2. UK Polymerase Chain Reaction Revenue, by End User, 2015 2023 (USD Billion)
7.3.4.3.
7.3.5. Germany
7.3.5.1. Germany Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.3.5.2. Germany Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.3.6. France
7.3.6.1. France Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.3.6.2. France Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.4.2. Asia Pacific Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.4.3. Asia Pacific Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.4.4. China
7.4.4.1. China Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.4.4.2. China Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.4.5. Japan
7.4.5.1. Japan Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.4.5.2. Japan Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.4.6. India
7.4.6.1. India Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.4.6.2. India Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.5. Latin America
7.5.1. Latin America Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.5.2. Latin America Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.5.3. Latin America Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.5.4. Brazil
7.5.4.1. Brazil Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.5.4.2. Brazil Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Polymerase Chain Reaction Market, 2015 2023 (USD Billion)
7.6.2. Middle East and Africa Polymerase Chain Reaction Market Revenue, by Product, 2015 2023 (USD Billion)
7.6.3. Middle East and Africa Polymerase Chain Reaction Market Revenue, by End User, 2015 2023 (USD Billion)
CHAPTER 8. COMPANY PROFILE
8.1. Affymetrix, Inc.
8.1.1. Overview
8.1.2. Financials
8.1.3. Therapy portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. Agilent Technologies, Inc.
8.2.1. Overview
8.2.2. Financials
8.2.3. Therapy portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. Sigma Aldrich Corporation
8.3.1. Overview
8.3.2. Financials
8.3.3. Therapy portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. Abbott Laboratories
8.4.1. Overview
8.4.2. Financials
8.4.3. Therapy portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. Beckman Coulter
8.5.1. Overview
8.5.2. Financials
8.5.3. Therapy portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. Bio-Rad Laboratories
8.6.1. Overview
8.6.2. Financials
8.6.3. Therapy portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. GE Healthcare
8.7.1. Overview
8.7.2. Financials
8.7.3. Therapy portfolio
8.7.4. Business strategy
8.7.5. Recent developments
8.8. QIAGEN
8.8.1. Overview
8.8.2. Financials
8.8.3. Therapy portfolio
8.8.4. Business strategy
8.8.5. Recent developments
8.9. Becton Dickinson Company
8.9.1. Overview
8.9.2. Financials
8.9.3. Therapy portfolio
8.9.4. Business strategy
8.9.5. Recent developments
8.10. Thermo Fischer
8.10.1. Overview
8.10.2. Financials
8.10.3. Therapy portfolio
8.10.4. Business strategy
8.10.5. Recent developments
